Jeffrey B. Kindler - Feb 22, 2022 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
Director
Signature
/s/ Jeffrey B. Kindler, by Donald P. Lehr, as attorney-in-fact
Stock symbol
PGEN
Transactions as of
Feb 22, 2022
Transactions value $
$69,000
Form type
4
Date filed
2/24/2022, 04:44 PM
Previous filing
Dec 8, 2021
Next filing
Mar 29, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGEN Common Stock Award $69K +34K +15.87% $2.03 248K Feb 22, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGEN Restricted Stock Units Award $0 +61.6K $0.00 61.6K Feb 22, 2022 Common Stock 61.6K Direct F2, F3
transaction PGEN Option to Purchase Common Stock (Right to Buy) Award $0 +83.2K $0.00 83.2K Feb 22, 2022 Common Stock 83.2K $2.03 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued to the reporting person in lieu of an annual retainer of $69,000.
F2 Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock.
F3 The RSUs vest in full on February 22, 2023.